Experts from the research and innovation community invited to tackle anti-microbial resistance

Researchers, policy-makers and business leaders from across the research and innovation community are invited to help tackle one of humanity’s biggest threats, anti-microbial resistance (AMR).

Novo’s weight loss drug helps curb some drinking habits, small study shows

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 13, 2025

Curaleaf Q1 Revenue Falls 2% Sequentially

Curaleaf Reports First Quarter 2023 Results First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million

May 18, 2023

Cancer drug offers life-changing results for severe lupus patient

The team at Charité – Universitätsmedizin Berlin is astounded by the huge improvement seen in a female patient with severe systemic lupus erythematosus (SLE) after

September 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.